RAS-RAF Pathway Deregulation
1 clinical trials · Condition
◉ Watch RAS-RAF Pathway Deregulation
| Record | Firm | Date |
|---|---|---|
| The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment (NCT03401957) | National Health Research Institutes, Taiwan | 2018-01-01 |
Track RAS-RAF Pathway Deregulation automatically
Every clearance here is in the API, with alerts when new ones post.